Dead or dying: Necrosis versus apoptosis in caspase-deficient human renal cell carcinoma

Cancer Research

Volumn 59, Issue 12, 1999, Pages 2838-2842

  Kolenko, Vladimir ^a   Uzzo, Robert G ^a   Bukowski, Ronald ^a   Bander, Neil H ^b   Novick, Andrew C ^a   Hsi, Eric D ^a   Finke, James H ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b WEILL CORNELL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE; ETHYLENEDIAMINE TETRAKIS(METHYLENEPHOSPHONIC ACID);

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL DEATH; ENZYME ACTIVATION; HUMAN; HUMAN CELL; KIDNEY CARCINOMA; NECROSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR CELL; TUMOR CELL DESTRUCTION;

APOPTOSIS; CARCINOMA, RENAL CELL; CASPASES; CHOLINESTERASE INHIBITORS; ETHYLENEDIAMINES; HUMANS; JURKAT CELLS; KIDNEY NEOPLASMS; KILLER CELLS, NATURAL; NECROSIS; T-LYMPHOCYTES; TUMOR CELLS, CULTURED;

EID: 0033564103     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Hannun, Y. A. Apoptosis and the dilemma of cancer chemotherapy. Blood, 89: 1845-1853, 1997.
2. Sayers, T. J., Brooks, A. D., Lee J. K., Fenton, R. G., Komschlies, K. L., Wigginton, J. M., Winkler-Pickett, R., and Wiltrout, R. H. Molecular mechanisms of immune-mediated lysis of murine renal cancer: differential contributions of perforin-dependent versus Fas-mediated pathways in lysis by NK and T cells. J. Immunol., 161: 3957-3965, 1998.
3. Earnshaw, W. C. Nuclear changes in apoptosis. Curr. Opin. Cell Biol., 7: 337-343, 1995.
4. Martinez-Lorenzo, M. J., Gamen, S., Etxeberria, J., Lasierra, P., Larrad, L., Pineiro, A., Anel, A., Naval, J., and Alava, M. A. Resistance to apoptosis correlates with a highly proliferative phenotype and loss of Fas and CPP32 (caspase-3) expression in human leukemia cells. Int. J. Cancer, 75: 473-481, 1998.
5. Coustan-Smith, E., Kitanaka, A., Pui, C. H., McNinch, L., Evans, W. E., Raimondi, S. C., Behm, F. G., Arico, M., and Campana, D. Clinical relevance of Bcl-2 overexpression in childhood acute lymphoblastic leukemia. Blood, 87: 1140-1146, 1996.
6. Zamzami, N., Susin, S. A., Marchetti, P., Hirsch, T., Gomez-Monterrey, I., Castedo, M., and Kroemer, G. Mitochondrial control of nuclear apoptosis. J. Exp. Med., 183: 1533-1544, 1996.
7. Green, D., and Kroemer, G. The central executioners of apoptosis: caspases or mitochondria? Trends Cell Biol., 8: 267-271, 1998.
8. Hirsch, T., Marchetti, P., Susin, S. A., Dallaporta, B., Zamzami, N., Marzo, I., Geuskens, M., and Kroemer, G. The apoptosis-necrosis paradox. Apoptogenic proteases activated after mitochondrial permeability transition determine the mode of cell death. Oncogene, 15: 1573-1581, 1997.
9. Ebert, T., Bander, N. H., Finstad, C. L., Ramsawak, R. D., and Old, L. J. Establishment and characterization of human renal cancer and normal kidney cell lines. Cancer Res., 50: 5531-5536, 1990.
10. Nicoletti, I., Migliorati, G., Pagliacci, M. C., Grignani, F., and Riccardi, C. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and now cytometry. J. Immunol. Methods, 139: 271-279, 1991.
11. Schreiber, E., Matthias, P., Muller, M. M., and Schaffner, W. Rapid detection of octamer binding proteins with "mini-extracts," prepared from a small number of cells. Nucleic Acids Res., 17: 6419, 1989.
12. Nicholson, D. W., and Thornberry, N. A. Caspases: killer proteases. Trends Biochem. Sci., 22: 299-306, 1997.
13. Salvesen, G. S., and Dixit, V. M. Caspases: intracellular signaling by proteolysis. Cell, 91: 443-446, 1997.
14. Rokhlin, O. W., Bishop, G. A., Hostager, B. S., Waldschmidt, T. J., Sidorenko, S. P., Pavloff, N., Kiefer, M. C., Umansky, S. R., Glover, R. A., and Cohen, M. B. Fas-mediated apoptosis in human prostatic carcinoma cell lines. Cancer Res., 57: 1758-1768, 1997.
15. Los, M., Herr, I., Friesen, C., Fulda, S., Schulze-Osthoff, K., and Debatin, K. M. Cross-resistance of CD95- and drug-induced apoptosis as a consequence of deficient activation of caspases (ICE/Ced-3 proteases). Blood, 90: 3118-3129, 1997.
16. Muller, M., Strand, S., Hug, H., Heinemann, E. M., Walczak, H., Hofmann, W. J., Stremmel, W., Krammer, P. H., and Galle, P. R. Drug-induced apoptosis in hepatoma cells is mediated by the CD95 (APO-1/Fas) receptor/ligand system and involves activation of wild-type p53. J. Clin. Invest., 99: 403-413, 1997.
17. Wolf, C. M., and Eastman, A. The temporal relationship between protein phosphatase, mitochondrial cytochrome c release and caspase activation in apoptosis. Exp. Cell. Res., 247: 505-513, 1999.
18. Green, D. R. Apoptotic pathways: the roads to ruin. Cell, 94: 695-698, 1998.
19. Green, D. R., and Reed, J. C. Mitochondria and apoptosis. Science (Washington DC), 281: 1309-1312, 1998.
20. Trapani, J. A., Jans, D. A., Jans, P. J., Smyth, M. J., Browne, K. A., and Sutton, V. R. Efficient nuclear targeting of granzyme B and the nuclear consequences of apoptosis induced by granzyme B and perform are caspase dependent, but cell death is caspase-independent. J. Biol. Chem., 273: 27934-27938, 1998.
21. Kluck, R. M., Bossy-Wetzel, E., Green, D. R., and Newmeyer, D. D. The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis Science (Washington DC), 275: 1132-1136, 1997.